Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,038 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Compulsory Licenses And Issues Related To It

    In general, a patent confers on its owner when granted, during the term of protection, the exclusive rights to prevent third parties from making, using, offering for sale, selling or importing of the patented invention ...
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Delhi High Court Bars Use Of 'Vigoura' To Protect Pfizer's Brand 'Viagra'

    The Delhi High Court, through its judgment in the case of Pfizer Products Inc. v. Renovision Exports Pvt. Ltd. and Anr CS(COMM) 378/2018, dated May 1, 2024, has decreed the suit in favour of the US-based drug major Pfizer Products Inc.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
Article

Legal Compliance Check For Your Home Bar In Delhi

Recently in Delhi, an FIR was filed against a man for storing 132 bottles of liquor at his house, containing 51.8 litres of whisky, vodka, gin, rum, and 55.4 litres of beer, wine.
IndiaLitigation, Mediation & Arbitration
S.S. Rana & Co.
S.S. Rana & Co.
  • Article

    European Medicines Agency (EMA): Recommends Approval Of Four Medicines In Its December Meeting

    Besremi was designated as an orphan medicinal product on December 09, 2011.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Covid-19 Vaccination In India

    01 Which are the COVID-19 vaccines that have been currently approved by the Indian Government?
    IndiaCoronavirus (COVID-19)
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    Companies CSR Amendment 2020

    Last year, in November 2019, a High- Level Committee (HLC) on Corporate Social Responsibility (CSR) was set up to review the CSR framework and make recommendations for developing a more robust...
    IndiaCorporate/Commercial Law
    HSA Advocates
    HSA Advocates
  • Article

    Checking The Pulse - Recent Legal Developments In The Indian Healthcare And Pharma Sector - June 1 - July 31, 2024

    As per Rule 161(iv) of GFRs, a GTE is floated when a particular Ministry or Department feels that the goods of required quality, specifications, etc., may not be available in India and finds it
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    Confusion Around The Status Of Electronic Nicotine Delivery Systems: Drug Or Poison?

    Variation in chemicals produce known and unknown toxicity which raises red flags about the safety and efficacy of this system.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    EMA Adopts ICH S9 Guideline On Non-Clinical Evaluation Of Anti-Cancer Pharmaceuticals

    On 16 May 2018, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted the ICH S9 guideline on non-clinical evaluation of anti-cancer pharmaceuticals (Step 5) ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Evolving Regulatory Framework For Novel Food In India

    Increased connectivity around the world has started a new wave in the market for novel foods. Novel foods such as genetically modified foods and food products, cell-based meat...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Spice Route Legal
    Spice Route Legal
  • Article

    Fixation Of Prices Of Drugs Under The DPCO , 2013: Application Of Para 19 Only In Extra-Ordinary Circumstances

    Indian Pharmaceutical Industry is at present, at its most progressive era where it has witnessed a robust growth over the past few years.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Impact Of Labeling And Display Regulations On The Food Processing Industry

    The FSSAI released a notification for new display and labeling regulations for processed foods, beverages and consumer foods in November 2020, which will be effective from 1 January 2022.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    India Healthcare Highlights July 2019

    This segment of the newsletter shares recent information associated with regulatory reforms from Healthcare and Pharmaceutical sectors from in Indian jurisdiction.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Ministry Of Health (Moh) Releases 3 Draft Gazettes Seeking Amendments To Drug & Cosmetics Rules, 1945

    However, it is also proposed that the permit holder should submit the details of the drugs imported and utilized, to the licensing authorities on a yearly basis from the date specified.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Multiple Sclerosis (MS) Drug Daclizumab (Zinbryta) Withdrawn From The Market

    On March 02, 2018, pharmaceutical companies Biogen and AbbVie announced that they are voluntarily withdrawing Daclizumab for relapsing multiple sclerosis off the global markets...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Osimertinib Granted Breakthrough Designation By FDA For 1st-line Treatment Of Patients With EGFR (Epidermal Growth Factor Receptor) Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)

    Osimertinib targets this secondary mutation that leads to disease progression.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Post Marketing Surveillance Of Drugs

    Post marketing surveillance is performed after market approval/clinical trials of drugs in India.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    The Fight Against Fake Food

    A trademark, by definition, is a word/phrase/symbol/design that is capable of distinguishing the source of the goods and/or services (in relation to which it is used) of one party from another.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    United States Food And Drug Administration Permits Marketing Of First Artificial Intelligence Based Device

    Diabetic retinopathy occurs when high levels of blood sugar lead to damage in the blood vessels of the retina, the light-sensitive tissues at the back of the eye.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    US FDA Highlights July 2019

    This segment discusses the recent drug approvals from the US FDA in various severe diseases. The write-ups describe the role of a new drug in the treatment of serious conditions such as myeloma
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Showing 421–440 of 1038 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics